Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
search
Subscribe
FREE
You must accept all conditions before being able to view the post
Continue
EUR
USA
EUR
USA
Therapy Area
Allergy & Immunology
Cardiology
Dermatology
Diabetes
Flagship Journal
Gastroenterology
General Healthcare
Hematology
Hepatology
Innovations
Interventional Cardiology
Microbiology & Infectious Diseases
Nephrology
Neurology
Oncology
Radiology
Reproductive Health
Respiratory
Rheumatology
Urology
Podcasts
Journals
Webinars
Collaborate
EMJ Media Pack
AMJ Media Pack
Editorial Enquiries
Contributors & Authors
Submit a Paper
Media Partners
Pharma Partners
EMJ Interactive
About
About
EQOH
Careers
Contact Us
EMJ Gold
Subscribe
FREE
Hematology
Filter
Journals
About
Congress reviews
Abstracts
Articles
Podcasts
Videos & Webinars
News
Infographics
Submit A Paper
TET2
Mutations Affect Stem Cell Response to Immune Stress
2
Mins
July 2024
Understanding how loss of function mutation of TET2 in haematopoietic stem cells (HSC) changes their response to stress is crucial to…
Read more
2
Mins
8 Aug 2017
The Simm Study: Survey of Integrative Medicine in Myeloproliferative Neoplasms
In patients with myeloproliferative neoplasms (MPN), including essential thrombocytosis (ET), polycythaemia vera (PV), and myelofibrosis (MF), symptoms…
2
Mins
8 Aug 2017
Targeting Nanoparticles to Chronic Lymphocytic Leukaemia: Exploiting the Properties of CXCR4
A key aim of modern cancer medicine is the improvement of treatment efficacy and overall patient health using targeted therapies.
2
Mins
8 Aug 2017
Haemoglobin Level and White Cell Count in Patients Clinically Suspected to have Essential Thrombocythaemia may help in Predicting Early Primary Myelofibrosis or Unclassifiable Myeloproliferative Neoplasm
Accurate diagnosis of essential thrombocythaemia (ET) and differentiation between ET and pre-fibrotic stages of primary myelofibrosis (PMF) can be…
1
Mins
8 Aug 2017
Front-Line Vascular Access Devices in Peripherally Inserted Acute Leukaemias: Central Catheter Versus Traditional Central Venous Catheter: A Phase IV Randomised Trial
For high-risk haematological patients, in particular those with acute leukaemia, there is limited information on the use of peripherally inserted…
1
Mins
8 Aug 2017
Oral Rigosertib Combined With Azacitidine in Patients with Myelodysplastic Syndromes and Acute Myeloid Leukaemia: Effects in Treatment Naïve and Relapsed/ Refractory Patients
Azacitidine is the standard of care for higher risk myelodysplastic syndromes (MDS); however, only approximately 50% of patients respond, and those…
2
Mins
8 Aug 2017
Minimal Residual Disease Monitoring by Digital PCR for JAK2V617F Detection in Patients with Myelofibrosis or Acute Myeloid Leukaemia Secondary to Myelofibrosis after Allogeneic Stem Cell Transplantation
Myelofibrosis (MF) is one of the BCR-ABL1-negative chronic myeloproliferative neoplasms (MPNs), characterised by clonal expansion of abnormal…
2
Mins
28 Jul 2016
Evidence-Based Transfusion Medicine for Coagulopathy of Chronic Liver Disease
Patients with chronic liver disease variably exhibit abnormalities of coagulation related to decreased synthesis of coagulation proteins. This results in…
2
Mins
28 Jul 2016
Management of Superficial Vein Thrombosis
Superficial vein thrombosis (SVT), indicating thrombosis of the superficial vein system, is less well-studied than deep vein thrombosis (DVT) because it…
Loading posts...
« Previous
1
…
4
5
6
7
Next »